Home
>
US Stocks
>
SpringWorks Therapeutics Inc
SpringWorks Therapeutics Inc
SWTX

SpringWorks Therapeutics Inc

$58.6523.31%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
62.28
Today Low/High
57.37 / 62.28
52 Week Low/High
$36.71 / $96.48
Market Cap
$3.68B

Company Details

SpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. SpringWorks has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers. SpringWorks' strategic approach and operational excellence in clinical development have enabled it to rapidly advance its two lead product candidates into late-stage clinical trials while simultaneously entering into multiple shared-value partnerships with industry leaders to expand its portfolio.
Organisation
SpringWorks Therapeutics Inc
Employees
78
Industry
Health Technology

Discover more

Frequently Asked Questions

What is SpringWorks Therapeutics Inc share price today

Can Indians buy SpringWorks Therapeutics Inc shares?

How can I buy SpringWorks Therapeutics Inc shares from India?

Can Fractional shares of SpringWorks Therapeutics Inc be purchased?

What are the documents required to start investing in SpringWorks Therapeutics Inc stocks?

We are a SEBI registered investement advisor